{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03040",
    "Peptide Name": "Ranatuerin-2PLx (R2PLx, natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a)",
    "Source": "skin secretions, the pickerel frog,Rana palustris, North America",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GIMDTVKNAAKNLAGQLLDKLKCSITAC",
    "Sequence Length": 28,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": 0.69,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "50%",
    "Crucial residues": "cysteine-bridged segment and cationincity within the loop domain in C-terminus are required for activity."
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that the sequence of the peptide shows 92.8% similarity toRanatuerin-2PLa. GRAVY: 0.23; Mol Wt: 2920.502; Mol formula: C124H221N33O39S3.Structure: In 50% TFE, it is helical.Activity: Active against S. aureus NCTC 10788 (MIC 32 uM) and E. coli NCTC 10418 (MIC 32 uM). Inactive: C.albicans NCTC 1467 (MIC 256 uM), MRSA ATCC 12493 (MIC 256 uM), E.fecalis NCTC 12697 (MIC 128 uM), and P.aeruginosa ATCC 27853 (MIC >512 uM).MOA:cancer: This peptide also inhibits the proliferation of several tumour cells, such as prostate cancer cell, PC-3, probably via apoptosis. Updated Jan2020; 7/2021",
    "Author": "Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T.2018",
    "Reference": "Biosci Rep. 2018 Nov 9;38(6):BSR20180710. doi: 10.1042/BSR20180710.PubMed",
    "Title": "A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells"
  },
  "3D Structure": []
}